Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases.

Seth N LevinShruthi VenkateshKatie E NelsonYi LiInes AguerreWen ZhuKarman MasownKathryn T RimmerClaudiu I DiaconuKaho B OnomichiVictoria M LeavittLibby L LevineRebecca Strauss-FarberWendy S VargasBrenda BanwellAmit Bar-OrJoseph R BergerAndrew D GoodmanErin E LongbrakeJiwon OhBianca Weinstock-GuttmanKiran T ThakurKeith R EdwardsClaire S RileyZongqi Xia Philip Lawrence De Jagernull null

Published in: Annals of clinical and translational neurology (2021)

Our study of real-time, patient-reported experience during the COVID-19 pandemic complements physician-reported MS case registries which capture an excess of severe cases. Overall, PwNID seem to have a risk of suspected COVID-19 similar to the reference population.

Keyphrases

patient reported
coronavirus disease
sars cov
primary care
emergency department
mass spectrometry
multiple sclerosis
pulmonary embolism
ms ms
early onset
drug induced